Wednesday October 24, 2018

High BP Medicine May Help Treat Migraine

Migraines are thought to affect a staggering one billion people worldwide

0
//
43
High BP Medicine May Help Treat Migraine
High BP Medicine May Help Treat Migraine. Pixabay
Republish
Reprint

A medication originally used to treat high blood pressure may help you from migraine pain attacks.
Candesartan – a drug used to treat high blood pressure – is just as effective as the commonly prescribed propranolol for migraine sufferers, according to a study.

The researchers also found that candesartan may work for patients who get no relief from propranolol.

“This gives doctors more possibilities and we can help more people,” said professor Lars Jacob Stovner, from Norwegian University of Science and Technology (NTNU).

“Candesartan is already in use by several doctors as a migraine preventive medicine but our follow-up study provides the proof that the drug actually works as a treatment,” said the researchers.

Representational image.
Representational image. Pixabay

The NTNU study was a triple blind test, which means that neither patients nor doctors nor those who analysed the results knew whether the patients had been given placebo or real medicine, Stovner said.

Researchers tested both candesartan and propranolol in 72 patients.

These patients were normally affected by migraine attacks at least twice every month.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks.

More than 20 percent of migraine patients reported that they feel better even when they are given a placebo.

Also Read: Why migraines are more common among women

But blind tests show that candesartan works preventively for another 20 to 30 percent of patients.

“The hope is now that candesartan will be even more commonly prescribed,” said Stovner.

Migraines are thought to affect a staggering one billion people worldwide. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Newly Developed Inhaler to Treat Migraine Without Medicine, says Study

While 45 per cent people experienced an effect the first time, and that number rose to 78 per cent the second time

0
Migraine
New inhaler can help treat migraine without medicine: Study. Pixabay

Some migraine patients can cut down on medication or stop using it completely by using a newly developed inhaler which changes the composition of the air we breathe, results of a clinical trial say.

Migraines occur as part of a chain reaction during which the veins in the brain contract and the blood cannot therefore supply the brain with sufficient oxygen, the researchers said.

In the study, the team from the Aarhus University in Denmark examined a small group of patients who suffer from migraine with aura, which is where they experience either sensory or visual disturbances before the painful headaches begin.

The novel inhaler slightly changes the body’s own molecules.

It utilises carbon dioxide and oxygen, which are the body’s natural molecules for mobilising its own defence against migraine attacks.

Migraine
Migraine is a risk factor for sudden sensorineural hearing loss — characterized by rapid loss of hearing in one or both ears, which may occur immediately or over the course of several days. Pixabay

“The inhaler expands the blood vessels that supply the brain with oxygen by up to seventy per cent and thereby stops the destructive chain reaction,” said Troels Johansen, from the varsity.

Johansen added that the effect of the treatment starts after a few seconds.

The results, published in the journal Cephalalgia, showed that the effect of the pain relief increased significantly with each use of the inhaler.

Also Read- Does Chiropractic Care Result in Vision Loss? Check out Here

While 45 per cent people experienced an effect the first time, and that number rose to 78 per cent the second time.

“The study shows some very significant physiological effects in the body,” Johansen said, adding that the team is now planning to conduct a large clinical trial that will also include migraine without aura and chronic migraine. (IANS)